Information  X 
Enter a valid email address

Broker Forecast - Bryan Garnier issues a broker note on GlaxoSmithKline PLC

By BFN News | 01:50 PM | Thursday 19 December, 2019

Bryan Garnier today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1747p (from 1660p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t